share_log

Cerence Inc. Reports Q4 Revenue Exceeding Guidance and Positive Cash Flow, Outlines FY25 Outlook

Cerence Inc. Reports Q4 Revenue Exceeding Guidance and Positive Cash Flow, Outlines FY25 Outlook

Cerence Inc.報告第四季度營業收入超出預期並實現正現金流,概述2025財年前景
Quiver Quantitative ·  11/21 20:11

Cerence Inc. reports strong Q4 revenue, positive cash flow, and plans for significant annual cost savings.

Quiver AI Summary

Cerence Inc. reported strong fourth quarter results for fiscal year 2024, with revenue of $54.8 million, exceeding expectations, and a positive cash flow from operations of $6.1 million. The company is on track with its transformation plan aimed at achieving annual cost savings of $35-$40 million. For fiscal year 2025, Cerence is providing revenue guidance of $236 to $247 million, bolstered by 22 platform launches in FY24, which included advancements in generative AI solutions. Despite a GAAP net loss of $20.4 million for Q4, CEO Brian Krzanich expressed optimism about the company's momentum and future prospects in the rapidly evolving automotive industry, focusing on enhancing efficiency and customer satisfaction. The company will hold a conference call to discuss these results in detail.

Potential Positives

  • Q4 revenue exceeded the high end of guidance, indicating strong performance and market confidence.
  • Positive cash flow from operations of $6.1 million demonstrates improved financial health and operational efficiency.
  • The transformation plan is on track to deliver significant annualized cost savings of $35-$40 million, which could lead to enhanced profitability.
  • Record high of 22 platform launches in FY24, including 6 for generative AI solutions, highlighting innovation and growth in strategic technology areas.

Potential Negatives

  • Significant GAAP net loss of $588.1 million for the fiscal year indicates severe financial challenges and ongoing operational issues.
  • GAAP operating margin of -174.9% for the fiscal year suggests that the company's operations are not sustainable in their current form.
  • Goodwill impairment charges totaling $609.2 million during the fiscal year raise concerns about the valuation of the company's assets and their future profitability.

FAQ

What were Cerence's Q4 revenue results?

Cerence's Q4 revenue exceeded the high end of guidance at $54.8 million, showing strong performance.

How much cash flow from operations did Cerence generate in Q4?

Cerence generated positive cash flow from operations of $6.1 million in Q4.

What is Cerence's revenue guidance for FY25?

The initial revenue guidance for FY25 is expected to be between $236 million to $247 million.

How many platform launches did Cerence achieve in FY24?

Cerence achieved a record high of 22 platform launches in FY24, including key generative AI solutions.

What is the expected impact of Cerence's transformation plan?

Cerence's transformation plan aims to deliver net annualized cost savings of $35 to $40 million.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


$CRNC Insider Trading Activity

$CRNC insiders have traded $CRNC stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here's a breakdown of recent trading of $CRNC stock by insiders over the last 6 months:

  • THOMAS L BEAUDOIN has traded it 7 times. They made 0 purchases and 7 sales, selling 41,403 shares.
  • JENNIFER SALINAS (EVP Chief Admin Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 20,127 shares.
  • NILS SCHANZ (EVP Product & Technology) has traded it 2 times. They made 0 purchases and 2 sales, selling 32,259 shares.
  • KATHERINE ROMAN (VP Corporate Controller) sold 2,225 shares.
  • STEFAN ORTMANNS (Chief Executive Officer) sold 9,542 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CRNC Hedge Fund Activity

We have seen 62 institutional investors add shares of $CRNC stock to their portfolio, and 153 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • VAN BERKOM & ASSOCIATES INC. removed 3,864,545 shares (-100.0%) from their portfolio in Q2 2024
  • FIRST TRUST ADVISORS LP removed 2,679,604 shares (-100.0%) from their portfolio in Q3 2024
  • CANADA LIFE ASSURANCE CO removed 1,118,646 shares (-100.0%) from their portfolio in Q3 2024
  • VANGUARD GROUP INC removed 868,146 shares (-21.8%) from their portfolio in Q3 2024
  • JACOBS LEVY EQUITY MANAGEMENT, INC added 823,428 shares (+inf%) to their portfolio in Q3 2024
  • ACADIAN ASSET MANAGEMENT LLC added 747,307 shares (+144.8%) to their portfolio in Q3 2024
  • ARISTOTLE CAPITAL BOSTON, LLC removed 625,952 shares (-100.0%) from their portfolio in Q2 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release




Headlines




  • Q4 Revenue exceeds high end of guidance; positive cash flow from operations of $6.1 million



  • Transformation plan on track to deliver net annualized cost savings of $35-$40 million



  • Initial FY25 revenue guidance of $236 to $247 million



  • Record high of 22 platform launches in FY24, including 6 for generative AI solutions and 4 in Q4



BURLINGTON, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today reported its fourth quarter and fiscal year 2024 results for the year ended September 30, 2024.




Results


Summary



(1




,2




)


(in millions, except per share data)




































































































































































































































































































Three Months Ended





Twelve Months Ended






September 30,





September 30,






2024





2023





2024





2023



GAAP revenue



$54.8




$80.8




$331.5




$294.5


GAAP gross margin




63.7

%




71.5

%




73.7

%




67.7

%

Non-GAAP gross margin




64.9

%




72.9

%




74.5

%




69.1

%

GAAP operating margin

(3)





-35.1

%




4.8

%




-174.9

%




-9.2

%

Non-GAAP operating margin




-7.2

%




17.8

%




21.8

%




10.8

%

GAAP net loss

(


3)




$(20.4

)



$(11.6

)



$(588.1

)



$(56.3

)

GAAP net loss margin

(3)





-37.3

%




-14.3

%




-177.4

%




-19.1

%

Non-GAAP net (loss) income



$(3.0

)



$3.8




$56.1




$14.6


Adjusted EBITDA



$(1.9

)



$16.6




$80.6




$41.5


Adjusted EBITDA margin




-3.5

%




20.5

%




24.3

%




14.1

%

GAAP net loss per share - diluted

(3)




$(0.49

)



$(0.29

)



$(14.12

)



$(1.40

)

Non-GAAP net (loss) income per share - diluted



$(0.07

)



$0.09




$1.23




$0.36

















(1)

As previously disclosed, Q1FY24 revenue includes the non-cash revenue associated with the Toyota "Legacy" contract and related impacts totaling $86.6M.

(2)

Please refer to the "Discussion of Non-GAAP Financial Measures" and "Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures" included elsewhere in this release for more information regarding our use of non-GAAP financial measures.

(3)

Includes a Goodwill impairment charge of $252M in Q2FY24 and $357M in Q3FY24.


Brian Krzanich, Chief Executive Officer of Cerence, commented, "The automotive industry is experiencing rapid transformation, and I am excited to have joined Cerence at this pivotal moment. We finished the fiscal year strong, with revenue exceeding the high end of our guidance."



Krzanich continued, "Throughout the course of the year, we gained critical momentum for our generative AI- and large language model-based solutions, with six generative AI program launches with leading automakers in fiscal 2024. As we work to advance and roll-out our next-gen roadmap, I look forward to leading the team toward our goals of increased efficiency and a high level of customer satisfaction, setting us up for anticipated sustainable, profitable growth in the years ahead."




Cerence Key Performance Indicators

To help investors gain further insight into the Cerence business and its performance, management provides a set of key performance indicators that includes:















































Key Performance Indicator



1




Q4FY24







Percent of worldwide auto production with Cerence Technology (TTM)

52%



Change in number of Cerence connected cars shipped

2

(TTM over prior year TTM)

16%



Change in Adjusted Total Billings (TTM over prior year TTM)

3


1%


(1)

Please refer to the "Key Performance Indicators" section included elsewhere in this release for more information regarding the definitions and our use of key performance indicators.

(2)

Based on IHS Markit data, global auto production increased 1% over the same time period ended on September 30, 2024.

(3)

Change in Adjusted total billings YoY (TTM): The year over year change in total billings adjusted to exclude Professional Services, prepay billings and adjusted for prepay consumption.



First Quarter and


Full Year


Fiscal 2025


Outlook



For the fiscal quarter ending December 31, 2024, revenue is expected to be in the range of $47 million to $50 million. GAAP net loss is expected to be in the range of ($26) million to ($23) million. Adjusted EBITDA is expected to be in the range of ($9) million to ($6) million.



For the full fiscal year ending September 30, 2025, the company expects revenue to be in the range of $236 million to $247 million which includes an estimated $20 million of fixed contracts at the mid-point of guidance. GAAP net loss is expected to be in the range of ($40) million to ($29) million. Adjusted EBITDA is expected to be in the range of $15 million to $26 million.



The adjusted EBITDA guidance excludes amortization of acquired intangible assets, stock-based compensation, restructuring and other costs.



Additional details regarding guidance will be provided during the earnings call.




Cerence Conference Call and Webcast

The company will host a live conference call and webcast with slides to discuss the results today at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time. Interested investors and analysts are invited to dial into the conference call by

registering here

.



Webcast access will also be available on the Investor Information section of the company's website at



.



A replay of the webcast can be accessed by visiting the company's website 90 minutes following the conference call at



.




Forward Looking Statements

Statements in this press release regarding: Cerence's future performance, results and financial condition; expected growth and profitability; outlook; transformation plans and cost efficiency initiatives, including the estimated net annualized cost savings; strategy; opportunities; business, industry and market trends; strategy regarding fixed contracts and its impact on financial results; backlog; revenue visibility; revenue timing and mix; demand for Cerence products; innovation and new product offerings, including AI technology; expected benefits of technology partnerships; and management's future expectations, estimates, assumptions, beliefs, goals, objectives, targets, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "believes," "plans," "goal," "anticipates," "projects," "forecasts," "expects," "intends," "continues," "will," "may," or "estimates" or similar expressions) should also be considered to be forward-looking statements. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risk, uncertainties and other factors, which may cause actual results or performance of the company to be materially different from any future results or performance expressed or implied by such forward-looking statements including but not limited to: the highly competitive and rapidly changing market in which we operate; adverse conditions in the automotive industry, the related supply chain and semiconductor shortage, or the global economy more generally; automotive production delays; changes in customer forecasts; the impacts of the COVID-19 pandemic on our and our customers' businesses; the ongoing conflicts in Ukraine and the Middle East; our inability to control and successfully manage our expenses and cash position; our inability to deliver improved financial results from process optimization efforts and cost reduction actions; escalating pricing pressures from our customers; the impact on our business of the transition to a lower level of fixed contracts, including the failure to achieve such a transition; our failure to win, renew or implement service contracts; the cancellation or postponement of existing contracts; the loss of business from any of our largest customers; effects of customer defaults; our inability to successfully introduce new products, applications and services; our strategies to increase cloud offerings and deploy generative AI and large language models (LLMs); the inability to expand into adjacent markets; the inability to recruit and retain qualified personnel; disruptions arising from transitions in management personnel, including the transition to our new Chief Executive Officer; cybersecurity and data privacy incidents; fluctuating currency rates and interest rates; inflation; restrictions on our current and future operations under the terms of our debt, the use of cash to service our debt; and our inability to generate sufficient cash from our operations; and the other factors discussed in our most recent Annual Report on Form 10-K, quarterly reports on Form 10-Q, and other filings with the Securities and Exchange Commission. We disclaim any obligation to update any forward-looking statements as a result of developments occurring after the date of this document.




Discussion of Non-GAAP Financial Measures

We believe that providing the non-GAAP information in addition to the GAAP presentation, allows investors to view the financial results in the way management views the operating results. We further believe that providing this information allows investors to not only better understand our financial performance, but more importantly, to evaluate the efficacy of the methodology and information used by management to evaluate and measure such performance. The non-GAAP information should not be considered superior to, or a substitute for, financial statements prepared in accordance with GAAP.



We utilize a number of different financial measures, both GAAP and non-GAAP, in analyzing and assessing the overall performance of the business, for making operating decisions and for forecasting and planning for future periods. While our management uses these non-GAAP financial measures as a tool to enhance their understanding of certain aspects of our financial performance, our management does not consider these measures to be a substitute for, or superior to, the information provided by GAAP financial statements.



Consistent with this approach, we believe that disclosing non-GAAP financial measures to the readers of our financial statements provides such readers with useful supplemental data that, while not a substitute for GAAP financial statements, allows for greater transparency in the review of our financial and operational performance. In assessing the overall health of the business during the three months ended September 30, 2024 and 2023, our management has either included or excluded the following items in general categories, each of which is described below.




Adjusted EBITDA.

Adjusted EBITDA is defined as net income attributable to Cerence Inc. before net income (loss) attributable to income tax (benefit) expense, other income (expense) items, net, depreciation and amortization expense, and excluding amortization of acquired intangible assets, stock-based compensation, and restructuring and other costs, net or impairment charges related to fixed and intangible assets and gains or losses on the sale of long-lived assets, if any. From time to time we may exclude from Adjusted EBITDA the impact of events, gains, losses or other charges (such as significant legal settlements) that affect the period-to-period comparability of our operating performance. Other income (expense) items, net include interest expense, interest income, and other income (expense), net (as stated in our Condensed Consolidated Statement of Operations). Our management and Board of Directors use this financial measure to evaluate our operating performance. It is also a significant performance measure in our annual incentive compensation programs.




Restructuring and other costs, net.

Restructuring and other costs, net include restructuring expenses as well as other charges that are unusual in nature, are the result of unplanned events, and arise outside the ordinary course of our business such as employee severance costs, consulting costs relating to our transformation initiatives, costs for consolidating duplicate facilities, third-party fees relating to the modification of our convertible debt, and the release of a pre-acquisition contingency.




Amortization of acquired intangible assets.

We exclude the amortization of acquired intangible assets from non-GAAP expense and income measures. These amounts are inconsistent in amount and frequency and are significantly impacted by the timing and size of acquisitions. Providing a supplemental measure which excludes these charges allows management and investors to evaluate results "as-if" the acquired intangible assets had been developed internally rather than acquired and, therefore, provides a supplemental measure of performance in which our acquired intellectual property is treated in a comparable manner to our internally developed intellectual property. Although we exclude amortization of acquired intangible assets from our non-GAAP expenses, we believe that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Future acquisitions may result in the amortization of additional intangible assets.




Non-cash expenses.

We provide non-GAAP information relative to the following non-cash expenses: (i) stock-based compensation; and (ii) non-cash interest. These items are further discussed as follows:












i)

Stock-based compensation. Because of varying valuation methodologies, subjective assumptions and the variety of award types, we exclude stock-based compensation from our operating results. We evaluate performance both with and without these measures because compensation expense related to stock-based compensation is typically non-cash and awards granted are influenced by the Company's stock price and other factors such as volatility that are beyond our control. The expense related to stock-based awards is generally not controllable in the short-term and can vary significantly based on the timing, size and nature of awards granted. As such, we do not include such charges in operating plans. Stock-based compensation will continue in future periods.

ii)

Non-cash interest. We exclude non-cash interest because we believe that excluding this expense provides management, as well as other users of the financial statements, with a valuable perspective on the cash-based performance and health of the business, including the current near-term projected liquidity. Non-cash interest expense will continue in future periods.



Other expenses.

We exclude certain other expenses that result from unplanned events outside the ordinary course of continuing operations, in order to measure operating performance and current and future liquidity both with and without these expenses. By providing this information, we believe management and the users of the financial statements are better able to understand the financial results of what we consider to be our organic, continuing operations. Included in these expenses are items such as other charges (credits), net, losses from extinguishment of debt, and changes in indemnification assets corresponding with the release of pre-spin liabilities for uncertain tax positions.




Adjustments to income tax provision.

Adjustments to our GAAP income tax provision to arrive at non-GAAP net income is determined based on our non-GAAP pre-tax income. Additionally, as our non-GAAP profitability is higher based on the non-GAAP adjustments, we adjust the GAAP tax provision to remove valuation allowances and related effects based on the higher level of reported non-GAAP profitability. We also exclude from our non-GAAP tax provision certain discrete tax items as they occur.




Key Performance Indicators



We believe that providing key performance indicators ("KPIs") allows investors to gain insight into the way management views the performance of the business. We further believe that providing KPIs allows investors to better understand information used by management to evaluate and measure such performance. KPIs should not be considered superior to, or a substitute for, operating results prepared in accordance with GAAP. In assessing the performance of the business during the three months ended September 30, 2024, our management has reviewed the following KPIs, each of which is described below:




  • Percent of worldwide auto production with Cerence Technology:

    The number of Cerence enabled cars shipped as compared to IHS Markit car production data.


  • Change in number of Cerence connected cars shipped:

    The year-over-year change in the number of cars shipped with Cerence connected solutions. Amounts calculated on a TTM basis.


  • Change in Adjusted total billings YoY (TTM):

    The year over year change in total billings excluding Professional Services, prepay billings and adjusted for prepay consumption.


____________



See the tables at the end of this press release for non-GAAP reconciliations to the most directly comparable GAAP measures.



To learn more about Cerence, visit



, and follow the company on

LinkedIn

.




About Cerence Inc.

Cerence (NASDAQ: CRNC) is the global industry leader in creating unique, moving experiences for the mobility world. As an innovation partner to the world's leading automakers and mobility OEMs, it is helping advance the future of connected mobility through intuitive, AI-powered interaction between humans and their vehicles, connecting consumers' digital lives to their daily journeys no matter where they are. Cerence's track record is built on more than 20 years of knowledge and 500 million cars shipped with Cerence technology. Whether it's connected cars, autonomous driving, e-vehicles, or two-wheelers, Cerence is mapping the road ahead. For more information, visit



.




Contact Information

Cerence Inc.
Investor Relations
Email:

investorrelations@cerence.com





CERENCE INC.


Consolidated Statements of Operations

(in thousands, except per share data)







































































































































































































































































































































































































































































































































































































































































Three Months Ended





Twelve Months Ended






September 30,





September 30,






2024





2023





2024





2023



Revenues:













License


$

25,341



$

43,105



$

124,746



$

145,159


Connected service



12,088




19,168




133,444




75,071


Professional service



17,376




18,491




73,314




74,245


Total revenues



54,805




80,764




331,504




294,475


Cost of revenues:













License



1,257




2,356




6,060




8,522


Connected service



6,407




4,777




24,787




22,995


Professional service



12,246




15,791




56,282




63,232


Amortization of intangible assets



-




104




103




414


Total cost of revenues



19,910




23,028




87,232




95,163


Gross profit



34,895




57,736




244,272




199,312


Operating expenses:













Research and development



25,227




35,143




121,563




123,333


Sales and marketing



4,827




5,848




21,725




27,504


General and administrative



13,185




11,450




52,468




57,903


Amortization of intangible assets



553




557




2,203




5,854


Restructuring and other costs, net



10,331




842




17,077




11,917


Goodwill impairment













609,172







Total operating expenses



54,123




53,840




824,208




226,511


(Loss) income from operations



(19,228

)



3,896




(579,936

)



(27,199

)

Interest income



1,444




1,231




5,353




4,471


Interest expense



(3,102

)



(3,132

)



(12,553

)



(14,769

)

Other income (expense), net



503




(1,649

)



2,526




1,108


(Loss) income before income taxes



(20,383

)



346




(584,610

)



(36,389

)

Provision for income taxes



33




11,898




3,468




19,865


Net loss


$

(20,416

)


$

(11,552

)


$

(588,078

)


$

(56,254

)

Net loss per share:













Basic



(0.49

)



(0.29

)



(14.12

)



(1.40

)

Diluted



(0.49

)



(0.29

)



(14.12

)



(1.40

)

Weighted-average common share outstanding:













Basic



41,866




40,357




41,642




40,215


Diluted



41,866




40,357




41,642




40,215





CERENCE INC.


Consolidated Balance Sheets

(in thousands, except per share amounts)






































































































































































































































































































































































































































September 30,





September 30,






2024





2023





ASSETS









Current assets:







Cash and cash equivalents


$

121,485



$

101,154


Marketable securities



5,502




9,211


Accounts receivable, net of allowances of $1,613 and $4,044 at September 30, 2024 and September 30, 2023, respectively



62,755




61,270


Deferred costs



5,286




6,935


Prepaid expenses and other current assets



70,481




47,157


Total current assets



265,509




225,727


Long-term marketable securities



3,453




10,607


Property and equipment, net



30,139




34,013


Deferred costs



18,051




20,299


Operating lease right of use assets



12,879




11,961


Goodwill



296,858




900,342


Intangible assets, net



1,706




3,875


Deferred tax assets



51,398




46,601


Other assets



22,365




44,165


Total assets


$

702,358



$

1,297,590




LIABILITIES AND STOCKHOLDERS' EQUITY









Current liabilities:







Accounts payable


$

3,959



$

16,873


Deferred revenue



52,822




77,068


Short-term operating lease liabilities



4,528




5,434


Short-term debt



87,094




-


Accrued expenses and other current liabilities



68,405




48,718


Total current liabilities



216,808




148,093


Long-term debt, net of discounts and issuance costs



194,812




275,951


Deferred revenue, net of current portion



114,354




145,531


Long-term operating lease liabilities



8,803




7,947


Other liabilities



26,484




25,193


Total liabilities



561,261




602,715


Stockholders' Equity:







Common stock, $0.01 par value, 560,000 shares authorized as of September 30, 2024; 41,924 and 40,423 shares issued and outstanding as of September 30, 2024 and September 30, 2023, respectively



419




404


Accumulated other comprehensive loss



(25,912

)



(27,966

)

Additional paid-in capital



1,088,330




1,056,099


Accumulated deficit



(921,740

)



(333,662

)

Total stockholders' equity



141,097




694,875


Total liabilities and stockholders' equity


$

702,358



$

1,297,590





CERENCE INC.


Consolidated Statements of Cash Flows

(in thousands)










































































































































































































































































































































































































































































Twelve Months Ended






September 30,






2024





2023




Cash flows from operating activities:








Net loss


$

(588,078

)


$

(56,254

)

Adjustments to reconcile net loss to net cash provided by operations:







Depreciation and amortization



10,630




16,038


Provision for credit loss reserve



3,545




3,626


Stock-based compensation



23,673




40,766


Non-cash interest expense



6,060




2,914


Loss on debt extinguishment



-




1,333


Deferred tax (benefit) provision



(4,658

)



7,597


Goodwill impairment



609,172




-


Unrealized foreign currency transaction gains



(1,454

)



(3,393

)

Other



(68

)



(3,388

)

Changes in operating assets and liabilities:







Accounts receivable



11,760




(16,964

)

Prepaid expenses and other assets



(12,466

)



28,192


Deferred costs



4,801




3,194


Accounts payable



(12,555

)



5,774


Accrued expenses and other liabilities



27,874




(408

)

Deferred revenue



(61,040

)



(21,529

)

Net cash provided by operating activities



17,196




7,498



Cash flows from investing activities:








Capital expenditures



(4,996

)



(5,124

)

Purchases of marketable securities



-




(18,025

)

Sale and maturities of marketable securities



11,112




30,324


Other investing activities



(1,737

)



(1,355

)

Net cash provided by investing activities



4,379




5,820



Cash flows from financing activities:








Proceeds from revolving credit facility



-




24,700


Payments of revolver credit facility



-




(24,700

)

Proceeds from long-term debt, net of discount



-




210,000


Payments for long-term debt issuance costs



(419

)



(17,176

)

Principal payments of long-term debt



-




(198,438

)

Common stock repurchases for tax withholdings for net settlement of equity awards



(9,865

)



(4,894

)

Principal payment of lease liabilities arising from a finance lease



(392

)



(451

)

Proceeds from the issuance of common stock



10,901




5,625


Net cash provided by (used in) financing activities



225




(5,334

)

Effects of exchange rate changes on cash and cash equivalents



(1,469

)



(1,677

)

Net change in cash and cash equivalents



20,331




6,307


Cash and cash equivalents at beginning of period



101,154




94,847


Cash and cash equivalents at end of period


$

121,485



$

101,154





CERENCE INC.


Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures

(unaudited - in thousands)



































































































































































































































































































































































































































































































































































































Three Months Ended





Twelve Months Ended






September 30,





September 30,






2024





2023





2024





2023




GAAP revenue




$



54,805





$



80,764





$



331,504





$



294,475

















GAAP gross profit




$



34,895





$



57,736





$



244,272





$



199,312



Stock-based compensation



685




1,004




2,633




3,703


Amortization of intangible assets



-




104




103




414



Non-GAAP gross profit




$



35,580





$



58,844





$



247,008





$



203,429




GAAP gross margin





63.7



%





71.5



%





73.7



%





67.7



%



Non-GAAP gross margin





64.9



%





72.9



%





74.5



%





69.1



%
















GAAP operating (loss) income




$



(19,228



)




$



3,896





$



(579,936



)




$



(27,199



)


Stock-based compensation



4,382




8,965




23,673




40,766


Amortization of intangible assets



553




661




2,306




6,268


Restructuring and other costs, net



10,331




842




17,077




11,917


Goodwill impairment



-




-




609,172




-



Non-GAAP operating (loss) income




$



(3,962



)




$



14,364





$



72,292





$



31,752




GAAP operating margin





-35.1



%





4.8



%





-174.9



%





-9.2



%



Non-GAAP operating margin





-7.2



%





17.8



%





21.8



%





10.8



%
















GAAP net loss




$



(20,416



)




$



(11,552



)




$



(588,078



)




$



(56,254



)


Stock-based compensation



4,382




8,965




23,673




40,766


Amortization of intangible assets



553




661




2,306




6,268


Restructuring and other costs, net



10,331




842




17,077




11,917


Goodwill impairment



-




-




609,172




-


Depreciation



2,028




2,226




8,324




9,770


Total other expense, net



(1,155

)



(3,550

)



(4,674

)



(9,190

)

Provision for income taxes



33




11,898




3,468




19,865



Adjusted EBITDA




$



(1,934



)




$



16,590





$



80,616





$



41,522




GAAP net loss margin





-37.3



%





-14.3



%





-177.4



%





-19.1



%



Adjusted EBITDA margin





-3.5



%





20.5



%





24.3



%





14.1



%





CERENCE INC.


Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)

(unaudited - in thousands, except per share data)


































































































































































































































































































































































































































































































































































































































































Three Months Ended





Twelve Months Ended






September 30,





September 30,






2024





2023





2024





2023




GAAP net loss




$



(20,416



)




$



(11,552



)




$



(588,078



)




$



(56,254



)


Stock-based compensation



4,382




8,965




23,673




40,766


Amortization of intangible assets



553




661




2,306




6,268


Restructuring and other costs, net



10,331




842




17,077




11,917


Loss on debt extinguishment



-




-




-




1,333


Goodwill impairment



-




-




609,172




-


Non-cash interest expense



1,579




1,464




6,060




2,914


Other



(31

)



500




(117

)



(344

)

Adjustments to income tax expense



574




2,870




(14,030

)



7,976



Non-GAAP net (loss) income




$



(3,028



)




$



3,750





$



56,063





$



14,576

















Adjusted EPS:















GAAP Numerator:














Net loss attributed to common shareholders - basic and diluted



$



(20,416



)




$



(11,552



)




$



(588,078



)




$



(56,254



)
















Non-GAAP Numerator:














Net (loss) income attributed to common shareholders - basic


$

(3,028

)


$

3,750



$

56,063



$

14,576


Interest on the Notes, net of tax



-




-




4,473




-


Net (loss) income attributed to common shareholders - diluted



$



(3,028



)




$



3,750





$



60,536





$



14,576

















GAAP Denominator:














Weighted-average common shares outstanding - basic and diluted




41,866






40,357






41,642






40,215

















Non-GAAP Denominator:














Weighted-average common shares outstanding- basic



41,866




40,357




41,642




40,215


Adjustment for diluted shares



-




1,101




7,727




423


Weighted-average common shares outstanding - diluted




41,866






41,458






49,369






40,638

















GAAP net loss per share - diluted




$



(0.49



)




$



(0.29



)




$



(14.12



)




$



(1.40



)



Non-GAAP net (loss) income per share - diluted




$



(0.07



)




$



0.09





$



1.23





$



0.36

















GAAP net cash provided by operating activities




$



6,115





$



11,258





$



17,196





$



7,498



Capital expenditures



(1,446

)



(1,527

)



(4,996

)



(5,124

)


Free Cash Flow




$



4,669





$



9,731





$



12,200





$



2,374






CERENCE INC.


Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)

(unaudited - in thousands)




















































































































































































































































































































































































































































































































































Q1 2025





FY2025






Low





High





Low





High




GAAP revenue




$



47,000





$



50,000





$



236,000





$



247,000

















GAAP gross profit




$



27,200





$



30,200





$



158,400





$



169,400



Stock-based compensation



700




700




2,500




2,500


Amortization of intangible assets



-




-




-




-



Non-GAAP gross profit




$



27,900





$



30,900





$



160,900





$



171,900




GAAP gross margin





58



%





60



%





67



%





69



%



Non-GAAP gross margin





59



%





62



%





68



%





70



%
















GAAP operating loss




$



(22,900



)




$



(19,900



)




$



(27,100



)




$



(16,100



)


Stock-based compensation



6,100




6,100




22,500




22,500


Amortization of intangible assets



500




500




1,600




1,600


Restructuring and other costs, net



5,600




5,600




8,100




8,100



Non-GAAP operating (loss) income




$



(10,700



)




$



(7,700



)




$



5,100





$



16,100




GAAP operating margin





-49



%





-40



%





-11



%





-7



%



Non-GAAP operating margin





-23



%





-15



%





2



%





7



%
















GAAP net loss




$



(26,400



)




$



(23,400



)




$



(39,600



)




$



(28,600



)


Stock-based compensation



6,100




6,100




22,500




22,500


Amortization of intangible assets



500




500




1,600




1,600


Restructuring and other costs, net



5,600




5,600




8,100




8,100


Depreciation



2,200




2,200




10,200




10,200


Total other expense, net



(1,700

)



(1,700

)



(5,100

)



(5,100

)

Provision for income taxes



1,800




1,800




7,400




7,400



Adjusted EBITDA




$



(8,500



)




$



(5,500



)




$



15,300





$



26,300




GAAP net loss margin





-56



%





-47



%





-17



%





-12



%



Adjusted EBITDA margin





-18



%





-11



%





6



%





11



%





CERENCE INC.


Reconciliations of GAAP Financial Measures to Non-GAAP Financial Measures (cont.)

(unaudited - in thousands, except per share data)





































































































































































































































































































































































































































































































Q1 2025





FY2025






Low





High





Low





High




GAAP net loss




$



(26,400



)




$



(23,400



)




$



(39,600



)




$



(28,600



)


Stock-based compensation



6,100




6,100




22,500




22,500


Amortization of intangible assets



500




500




1,600




1,600


Restructuring and other costs, net



5,600




5,600




8,100




8,100


Non-cash interest expense



1,600




1,600




5,500




5,500


Other



-




-




(100

)



(100

)

Income tax impact of Non-GAAP adjustments



(1,100

)



(1,100

)



(4,600

)



(4,600

)


Non-GAAP net (loss) income




$



(13,700



)




$



(10,700



)




$



(6,600



)




$



4,400

















Adjusted EPS:















GAAP Numerator:














Net loss attributed to common shareholders - basic and diluted



$



(26,400



)




$



(23,400



)




$



(39,600



)




$



(28,600



)
















Non-GAAP Numerator:














Net (loss) income attributed to common shareholders - basic and diluted



$



(13,700



)




$



(10,700



)




$



(6,600



)




$



4,400

















GAAP Denominator:














Weighted-average common shares outstanding - basic and diluted




42,900






42,900






43,000






43,000

















Non-GAAP Denominator:














Weighted-average common shares outstanding- basic



42,900




42,900




43,000




43,000


Adjustment for diluted shares



-




-




-




100


Weighted-average common shares outstanding - diluted




42,900






42,900






43,000






43,100

















GAAP net loss per share - diluted




$



(0.62



)




$



(0.55



)




$



(0.92



)




$



(0.67



)



Non-GAAP net (loss) income per share - diluted




$



(0.32



)




$



(0.25



)




$



(0.15



)




$



0.10




声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論